See what questions
a doctor would ask.
Pfizer's new drug, Lyrica (pregabalin) was last week approved by the FDA to treat pain associated with diabetic neuropathy. The drug claims to be well-tolerated by patients and is effective in reducing pain as well as the added bonus of improving sleep. The benefits were noticed within one week of commencing treatment during trials. Side effects were mostly mild cases of dizziness and sleepiness.
Source: summary of medical news story as reported by Reuters Health
About: New drug approved for treatment of pain associated with diabetic neuropathy
Date: 7 January 2005
Source: Reuters Health
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City